Functional Outcomes in Head and Neck Cancer Patients
- PMID: 35565265
- PMCID: PMC9099625
- DOI: 10.3390/cancers14092135
Functional Outcomes in Head and Neck Cancer Patients
Abstract
With the increase in long-term survivorship of head and neck cancer (HNC), the functional outcomes are gaining importance. We reported the functional outcomes of HNC patients using the HNC-Functional InTegrity (FIT) Scales, which is a validated tool for the rapid clinical assessment of functional status based on observable clinical criteria. Patients with newly diagnosed HNC treated at the Medical University of Innsbruck between 2008 and 2020 were consecutively included, and their status in the six functional domains of food-intake, breathing, speech, pain, mood, and neck and shoulder mobility was scored by the treating physician at oncological follow-up visits on a scale from 0 (loss of function) to 4 (full function). HNC-FIT scales were available for 681 HNC patients at a median of 35 months after diagnosis. The response status was complete remission in 79.5%, 18.1% had recurrent or persistent disease, and 2.4% had a second primary HNC. Normal or near-normal scores (3 and 4) were seen in 78.6% for food intake, 88.7% for breathing, 83.7% for speech, 89% for pain, 91.8% for mood, and 87.5% for neck and shoulder mobility. A normal or near-normal outcome in all six functional domains was observed in 61% of patients. Clinically relevant impairment (score 1-2) in at least one functional domain was observed in 30%, and 9% had loss of function (score 0) in at least one functional domain. The main factors associated with poor functional outcome in a multivariable analysis were recurrence or persistent disease, poor general health (ASA III and IV), and higher T stage. Particularly, laryngeal and hypopharyngeal tumors impaired breathing and speech function, and primary radiation therapy or concomitant systemic therapy and radiotherapy worsened food intake. Clinically relevant persistent functional deficits in at least one functional domain must be expected in 40% of the patients with HNC. The treatment of these functional deficits is an essential task of oncologic follow-up.
Keywords: functional outcomes; head and neck neoplasms; health status; questionnaire design; surveys and questionnaires.
Conflict of interest statement
The authors declare no conflict of interest.
Figures


Similar articles
-
A Tool for Rapid Assessment of Functional Outcomes in Patients with Head and Neck Cancer.Cancers (Basel). 2021 Nov 3;13(21):5529. doi: 10.3390/cancers13215529. Cancers (Basel). 2021. PMID: 34771691 Free PMC article.
-
Long-term quality of life for surgical and nonsurgical treatment of head and neck cancer.Arch Otolaryngol Head Neck Surg. 2005 Oct;131(10):879-85. doi: 10.1001/archotol.131.10.879. Arch Otolaryngol Head Neck Surg. 2005. PMID: 16230590
-
Depression as a predictor of postoperative functional performance status (PFPS) and treatment adherence in head and neck cancer patients: a prospective study.J Otolaryngol Head Neck Surg. 2015 Sep 18;44(1):38. doi: 10.1186/s40463-015-0092-4. J Otolaryngol Head Neck Surg. 2015. PMID: 26385356 Free PMC article.
-
Nutrition impact symptoms and associated outcomes in post-chemoradiotherapy head and neck cancer survivors: a systematic review.J Cancer Surviv. 2018 Aug;12(4):479-494. doi: 10.1007/s11764-018-0687-7. Epub 2018 Mar 20. J Cancer Surviv. 2018. PMID: 29556926
-
State of Rehabilitation Research in the Head and Neck Cancer Population: Functional Impact vs. Impairment-Focused Outcomes.Curr Oncol Rep. 2022 Apr;24(4):517-532. doi: 10.1007/s11912-022-01227-x. Epub 2022 Feb 19. Curr Oncol Rep. 2022. PMID: 35182293 Review.
Cited by
-
30-hydroxygambogic acid increases the efficacy of cisplatin in an HPV+ head and neck cancer in vivo model.BMC Cancer. 2025 Aug 1;25(1):1251. doi: 10.1186/s12885-025-14638-3. BMC Cancer. 2025. PMID: 40745291 Free PMC article.
-
Cetuximab-Toxin Conjugate and NPe6 with Light Enhanced Cytotoxic Effects in Head and Neck Squamous Cell Carcinoma In Vitro.Biomedicines. 2024 Apr 29;12(5):973. doi: 10.3390/biomedicines12050973. Biomedicines. 2024. PMID: 38790935 Free PMC article.
-
Outcomes of Management of Advanced oral Cavity Carcinoma (T3 and T4) Following Surgery and Chemoradiotherapy Among Rural Population in Gujarat.Indian J Otolaryngol Head Neck Surg. 2025 Mar;77(3):1485-1491. doi: 10.1007/s12070-025-05364-0. Epub 2025 Feb 5. Indian J Otolaryngol Head Neck Surg. 2025. PMID: 40093495
-
Outcomes Following Autologous Fat Grafting in Patients with Sequelae of Head and Neck Cancer Treatment.Cancers (Basel). 2023 Jan 28;15(3):800. doi: 10.3390/cancers15030800. Cancers (Basel). 2023. PMID: 36765758 Free PMC article.
-
Psychometric validation of the Chinese version of the Edmonton-33 scale in patients with head and neck cancer.Asia Pac J Oncol Nurs. 2025 Mar 8;12:100685. doi: 10.1016/j.apjon.2025.100685. eCollection 2025 Dec. Asia Pac J Oncol Nurs. 2025. PMID: 40271524 Free PMC article.
References
LinkOut - more resources
Full Text Sources